|
|
|
Heron Therapeutics CEO Barry Quart & President John Poyhonen deliver a formal corporate overview, followed by a Q & A session moderated by Noble Capital Markets Senior Healthcare Services & Medical Devices Analyst Gregory Aurand. Return to the Investor Forum Event Page
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com. |
Heron Therapeutics (HRTX) – New Developments in Pain Management – a NobleCon Online Investor Event
